Form 4: Surgery Partners Executive Anthony Taparo Receives Restricted Stock Awards

Anthony Taparo, Chief Growth Officer of Surgery Partners, Inc., was granted restricted stock awards on February 28, 2024, increasing his beneficial ownership in the company.

Summary

• Anthony Taparo, Chief Growth Officer of Surgery Partners, Inc., received restricted stock awards on February 28, 2024.
• He acquired 8,338 shares of common stock at a price of $31.18 per share, which vest in three equal annual installments starting on the first anniversary of the grant date.
• Additionally, he acquired 2,084 shares of common stock at the same price, which vest in two equal annual installments beginning on the first anniversary of the grant date.
• Following these transactions, Taparo's total beneficial ownership in Surgery Partners, Inc. common stock increased to 105,106 shares.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The granting of stock awards suggests confidence in the company's future, but it's a routine transaction.

Positives

• The grant of restricted stock awards to a key executive like the Chief Growth Officer can be seen as a positive sign, aligning his interests with the long-term success of the company.
• The vesting schedule encourages the executive's continued service and contribution to the company's growth.

Industry Context

Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors to gauge management's sentiment and alignment with shareholder interests.

Comparison to Industry Standards

• Restricted stock awards are a common form of executive compensation in the healthcare industry, used to incentivize performance and retain key talent.
• The vesting schedules, typically ranging from two to four years, are in line with industry norms.
• Comparing the size of the awards to those of executives at similar companies like AmSurg or Envision Healthcare would provide further context on the competitiveness of Surgery Partners' compensation practices.

Stakeholder Impact

• Shareholders may view the stock awards positively, as they align management's interests with the company's performance.
• Employees may see it as a sign of the company's commitment to its leadership team.

Key Dates